glp 1 agonist in ckd Glucagon-like peptide-1 receptor agonists diabetic kidney disease: A review of their kidney and heart protection Glucagon-Like Peptide-1 Receptor Agonist Use
Description
Malone, J
[DOI] [PubMed] [Google Scholar] 506.Vilsboll T., Krarup T., Madsbad S., Holst J.J
Therefore, the development of mild retinopathy, which could be a few intraretinal hemorrhages, was considered an adverse event
PubMed CrossRef Li S, Sabbah SG, Kwan ATH, et al
In bone, GLP-1 binding to its receptor promotes bone marrow mesenchymal stem cell osteoblast differentiation and inhibits its differentiation into fat cells, thereby promoting bone formation and improving osteoporosis [15]
Studies have also reported that under the conditions of comparable glycemic control, liraglutide (1.2 mg/d) alone was more effective than liraglutide with metformin or metformin alone on lipid metabolism and cardiovascular protection [36]
